Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E McCormack

Showing results (221-230 of 240) with videos related to

Pageof 24
Sort By:
JAMA Oncology|July 29, 2021
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical TrialHeath Skinner, Chen Hu, Theodoros Tsakiridis, et al.
JCI Insight|November 5, 2016
Muscle oxidative phosphorylation quantitation using creatine chemical exchange saturation transfer (CrCEST) MRI in mitochondrial disordersCatherine DeBrosse, Ravi Prakash Reddy Nanga, Neil Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Early human B cell signatures of the primary antibody response to mRNA vaccinationLela Kardava, Nicholas Rachmaninoff, William W Lau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titerP L Sheridan, M Bodner, A Lynn, et al.
Cell|October 18, 2022
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responsesClarisa M Buckner, Lela Kardava, Omar El Merhebi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccinationClarisa M Buckner, Lela Kardava, Omar El Merhebi, et al.
The Lancet. Neurology|April 20, 2026
Safety and efficacy of individualised exercise and NAD<sup>+</sup> precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trialKimberly Y Lin, Anna Bucha, Kara McSweeney, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccineLela Kardava, Nicholas Rachmaninoff, William W Lau, et al.
JCI Insight|August 22, 2024
NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's AtaxiaCaroline E Perry, Sarah M Halawani, Sarmistha Mukherjee, et al.
ESC Heart Failure|May 15, 2021
Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolismPayman Zamani, Elizabeth A Proto, Neil Wilson, et al.
Pageof 24

Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
JAMA Oncology|July 29, 2021
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer: The NRG-LU001 Phase 2 Randomized Clinical TrialHeath Skinner, Chen Hu, Theodoros Tsakiridis, et al.
JCI Insight|November 5, 2016
Muscle oxidative phosphorylation quantitation using creatine chemical exchange saturation transfer (CrCEST) MRI in mitochondrial disordersCatherine DeBrosse, Ravi Prakash Reddy Nanga, Neil Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2022
Early human B cell signatures of the primary antibody response to mRNA vaccinationLela Kardava, Nicholas Rachmaninoff, William W Lau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2000
Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titerP L Sheridan, M Bodner, A Lynn, et al.
Cell|October 18, 2022
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responsesClarisa M Buckner, Lela Kardava, Omar El Merhebi, et al.
Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccinationClarisa M Buckner, Lela Kardava, Omar El Merhebi, et al.
The Lancet. Neurology|April 20, 2026
Safety and efficacy of individualised exercise and NAD<sup>+</sup> precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trialKimberly Y Lin, Anna Bucha, Kara McSweeney, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2021
Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccineLela Kardava, Nicholas Rachmaninoff, William W Lau, et al.
JCI Insight|August 22, 2024
NAD+ precursors prolong survival and improve cardiac phenotypes in a mouse model of Friedreich's AtaxiaCaroline E Perry, Sarah M Halawani, Sarmistha Mukherjee, et al.
ESC Heart Failure|May 15, 2021
Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolismPayman Zamani, Elizabeth A Proto, Neil Wilson, et al.
Pageof 24